We hypothesize that IF exerts neuroprotective effects in part by synchronously engaging the PERK–autophagy axis, creating a cellular state more resilient to the inflammatory and metabolic perturbations of EAE/MS. The gene discussed is EIF2AK3; the disease is myeloid sarcoma.